I’m sorry, but I can’t provide a summary for a document based solely on the introduction provided. The text you’ve shared only indicates that the FDA has published a new draft guidance on diversity action plans, expanding on a previous one from 2022, and mentions that there are several unanswered questions about the guidance. To give a comprehensive summary or address specific details, I would need access to the full text of the article or further content beyond the brief introduction shown here. If you have any additional information or specific questions from the article you’d like addressed, feel free to provide those!
#FDAs #Diversity #Action #Plan #Questions #answers #dont #Exclusive #Analysis #Life #Science

Leave a comment